Literature DB >> 32888393

Characterization of the Robinow syndrome skeletal phenotype, bone micro-architecture, and genotype-phenotype correlations with the osteosclerotic form.

Brian J Shayota1, Chaofan Zhang1, Roman J Shypailo2, Juliana F Mazzeu3, Claudia M B Carvalho1, V Reid Sutton1,4.   

Abstract

Robinow syndrome (RS) is a genetically heterogeneous skeletal dysplasia with recent reports suggesting an osteosclerotic form of the disease. We endeavored to investigate the full spectrum of skeletal anomalies in a genetically diverse cohort of RS patients with a focus on the bone micro-architecture. Seven individuals with molecularly confirmed RS, including four with DVL1 variants and single individuals with variants in WNT5A, ROR2, and GPC4 underwent a musculoskeletal focused physical examination, dual-energy X-ray absorptiometry (DEXA) scan, and high-resolution peripheral quantitative computed tomography (HR-pQCT). Skeletal examination revealed variability in limb shortening anomalies consistent with recent reports. DEXA scan measures revealed increased total body bone mineral density (BMD) (3/7), cranial BMD (5/7), and non-cranial BMD (1/7). Cranial osteosclerosis was only observed in DVL1-RS (4/4) and GPC4-RS (1/1) subjects and in one case was complicated by choanal atresia, bilateral conductive hearing loss, and cranial nerve III, VI, and VII palsy. HR-pQCT revealed a unique pattern of low cortical BMD, increased trabecular BMD, decreased number of trabeculations, and increased thickness of the trabeculations for the DVL1-RS subjects. The spectrum of skeletal anomalies including the micro-architecture of the bones observed in RS has considerable variability with some osteosclerosis genotype-phenotype correlations more frequent with DVL1 variants.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  DEXA; DVL1; HR-pQCT; Robinow syndrome; WNT5A; bone density

Mesh:

Substances:

Year:  2020        PMID: 32888393     DOI: 10.1002/ajmg.a.61843

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Phenotypic and mutational spectrum of ROR2-related Robinow syndrome.

Authors:  Ariadne R Lima; Barbara M Ferreira; Chaofan Zhang; Angad Jolly; Haowei Du; Janson J White; Moez Dawood; Tulio C Lins; Marcela A Chiabai; Ellen van Beusekom; Mara S Cordoba; Erica C C Caldas Rosa; Hulya Kayserili; Virginia Kimonis; Erica Wu; Cecilia Mellado; Vineet Aggarwal; Antonio Richieri-Costa; Décio Brunoni; Talyta M Canó; Alexander A L Jorge; Chong A Kim; Rachel Honjo; Débora R Bertola; Raissa M Dandalo-Girardi; Yavuz Bayram; Alper Gezdirici; Elif Yilmaz-Gulec; Evren Gumus; Gülay C Yilmaz; Nobuhiko Okamoto; Hirofumi Ohashi; Zeynep Coban-Akdemir; Tadahiro Mitani; Shalini N Jhangiani; Donna M Muzny; Neysa A P Regattieri; Robert Pogue; Rinaldo W Pereira; Paulo A Otto; Richard A Gibbs; Bassam R Ali; Hans van Bokhoven; Han G Brunner; V Reid Sutton; James R Lupski; Angela M Vianna-Morgante; Claudia M B Carvalho; Juliana F Mazzeu
Journal:  Hum Mutat       Date:  2022-05-10       Impact factor: 4.700

2.  Novel pathogenic variants and quantitative phenotypic analyses of Robinow syndrome: WNT signaling perturbation and phenotypic variability.

Authors:  Chaofan Zhang; Angad Jolly; Brian J Shayota; Juliana F Mazzeu; Haowei Du; Moez Dawood; Patricia Celestino Soper; Ariadne Ramalho de Lima; Bárbara Merfort Ferreira; Zeynep Coban-Akdemir; Janson White; Deborah Shears; Fraser Robert Thomson; Sarah Louise Douglas; Andrew Wainwright; Kathryn Bailey; Paul Wordsworth; Mike Oldridge; Tracy Lester; Alistair D Calder; Katja Dumic; Siddharth Banka; Dian Donnai; Shalini N Jhangiani; Lorraine Potocki; Wendy K Chung; Sara Mora; Hope Northrup; Myla Ashfaq; Jill A Rosenfeld; Kati Mason; Lynda C Pollack; Allyn McConkie-Rosell; Wei Kelly; Marie McDonald; Natalie S Hauser; Peter Leahy; Cynthia M Powell; Raquel Boy; Rachel Sayuri Honjo; Fernando Kok; Lucia R Martelli; Vicente Odone Filho; Donna M Muzny; Richard A Gibbs; Jennifer E Posey; Pengfei Liu; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  HGG Adv       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.